醫學動畫市場 - 全球產業規模、佔有率、趨勢、機會及預測（按類型、治療領域、應用、最終用戶、地區和競爭格局分類，2021-2031年）

全球醫療動畫市場預計將從 2025 年的 4.05 億美元成長到 2031 年的 7.4302 億美元，複合年成長率達到 10.87%。

該領域涉及數位影片的商業性製作，旨在闡明複雜的生物學和外科手術主題，用於教育和市場推廣。推動這一成長的關鍵因素包括現代藥物治療日益複雜，需要藉助視覺化方式進行解釋，以及患者越來越依賴數位工具來提升自身健康素養。此外，業界的巨額投資也進一步刺激了這項需求。根據美國藥品研究與製造商協會 (PhRMA) 預測，其成員公司將在 2024 年投入約 1,010 億美元用於研發，因此，嚴謹的科學視覺化對於有效傳達這些創新成果至關重要。

然而，高昂的製作成本和專業人才的匱乏是阻礙市場發展的重要障礙。開發醫學上精確的3D視覺化模型需要精通生命科學和動畫軟體的專家，這顯著增加了人事費用和服務價格。因此，這一經濟障礙限制了預算有限的中小型醫療機構和教育機構獲得專業動畫服務的機會。

市場促進因素

藥品行銷和推廣支出的不斷成長是市場成長的主要驅動力。製藥商正大力投資高品質的視覺素材，以在競爭激烈的市場中脫穎而出。為了清楚地向醫生和直接面對消費者（DTC）的受眾傳達複雜的治療方法作用機制（MOA），各公司正利用醫學動畫將靜態的臨床數據轉化為引人入勝、通俗易懂的故事。這一趨勢也得到了財務數據的支持。根據Fierce Pharma於2025年6月發布的報告，製藥公司在2024年將在所有管道的處方藥行銷上投入超過101億美元，這將對數位內容創作產生巨大的需求。推廣活動的擴張將確保能夠提供科學嚴謹且符合規範的視覺敘事的動畫工作室擁有源源不絕的合約。

此外，數位健康平台和行動應用程式的激增正在加速需求成長。隨著診斷和患者管理工具日益複雜，尤其是在軟體成為現代醫療設備和患者照護策略的核心組成部分之後，清晰的動畫說明和介面視覺化對於確保用戶安全和正確使用至關重要。根據 MedTech Dive 2025 年 5 月報道，截至當時，美國食品藥物管理局(FDA) 已核准約 950 種人工智慧或機器學習醫療設備，這使得對大量教學可視化庫的需求日益成長，以支持這些設備的應用。整個產業的投資成長推動了這項需求的擴張。英國製藥工業協會 (BPIA) 預測，截至 2025 年，全球製藥研發投資預計將保持近年來 6.6% 的複合年成長率，這將推動需要可視化的創新技術的持續發展。

市場挑戰

高昂的製作成本加上專業人才短缺，是全球醫學動畫市場擴張的主要障礙。這項雙重挑戰使得高品質的視覺化內容價格高昂，令大量潛在客戶（尤其是中小醫療機構、學術機構和區域性醫療設備製造商）難以進入市場。儘管對精準科學可視化的需求不斷成長，但供應方無法以經濟高效的方式擴大生產規模，造成了供應瓶頸。因此，市場仍然由資金雄厚的製藥巨頭主導，導致整個中端市場需求不足，並限制了整體收入成長。

造成這種財務柔軟性不足的根本原因是合格專業人才短缺。製作醫學上精確的3D內容需要同時具備生命科學高階教育背景和技術動畫軟體技能的人才。由於各工作室競相爭取有限的資源，這種人才短缺推高了人事費用。根據醫學插畫家協會預測，到2024年，該行業仍將嚴重供不應求，每年僅有約50-60名獲得認證的碩士學位畢業生進入該領域。這種專業人才的持續供不應求導致製作成本居高不下，阻礙了市場採用更具競爭力的定價模式，也限制了產業的全面成長。

市場趨勢

採用由生成式人工智慧驅動的自動化工作流程正在變革醫療動畫供應鏈，顯著減少製作高清內容所需的時間和資金。透過自動化紋理、燈光和初步建模等勞動密集任務，工作室可以緩解行業人才短缺和高成本的問題，而這些問題歷來阻礙市場准入。這種向人工智慧驅動的效率提升的轉變帶來了即時的經濟效益。根據英偉達2025年3月發布的報告《醫療保健和生命科學領域的人工智慧現狀：2025年趨勢》，45%使用生成式人工智慧的醫療機構表示，他們在12個月內實現了投資回收期。這些營運效率的提升使機構能夠提供具有競爭力的價格，從而將市場開放給以前難以進入的中小型醫療和教育機構。

同時，個人化、患者特定視覺化技術的興起正將整個產業從通用素材的生產者轉變為客製化治療溝通工具的提供者。隨著病人參與日益重要，市場對不依賴標準解剖結構、而是能夠根據個體病理動態客製化的動畫的需求也日益成長，從而直接應對健康素養方面的挑戰。打擊錯誤訊息更凸顯了這項需求。根據愛思唯爾健康於2025年7月發布的《未來臨床醫師2025》報告，59%的臨床醫師表示，醫療錯誤訊息會阻礙病患堅持建議的治療方案。因此，市場正在轉向即時渲染平台，使醫生能夠在諮詢過程中可視化具體的手術方案和疾病進展，從而確保患者準確理解並堅持治療。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球醫學動畫市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依類型（3D動畫、2D動畫、4D動畫、Flash動畫）
  • 依治療領域（腫瘤科、心臟科、整形外科、牙科、其他）
  • 按應用領域（藥物作用機制、病患教育、外科手術訓練與計畫、細胞與分子研究等）
  • 按最終用戶分類（醫院、生命科學公司、學術機構、醫療設備製造商等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美醫療動畫市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲醫療動畫市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章 亞太地區醫療動畫市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲醫療動畫市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲醫療動畫市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球醫療動畫市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Wiley
• Elsevier
• XVIVO
• Nucleus Medical Media
• Blausen Medical
• Ghost Productions
• Anatomage
• Touch Surgery
• Medis Media
• BioDigital

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Medical Animation Market is projected to expand from USD 400.05 Million in 2025 to USD 743.02 Million by 2031, achieving a compound annual growth rate of 10.87%. This sector involves the commercial creation of digitally generated moving images intended to clarify complex biological or surgical topics for educational and marketing purposes. Key factors fueling this growth include the increasing intricacy of modern pharmaceutical treatments, which necessitate visual explanations, and a growing dependence on digital tools to improve patient health literacy. This demand is reinforced by substantial industry investment; according to the Pharmaceutical Research and Manufacturers of America, member companies allocated nearly $101 billion to research and development in 2024, generating a critical need for precise scientific visualization to effectively convey these innovations.

However, a major obstacle potentially hindering market progress is the prohibitive cost of production coupled with a lack of specialized talent. Developing medically accurate 3D visuals demands professionals who possess dual expertise in both life sciences and animation software, a requirement that significantly elevates labor costs and service pricing. Consequently, this financial hurdle restricts the utilization of professional animation services among smaller healthcare providers and educational institutions operating with limited budgets.

Market Driver

Increasing pharmaceutical marketing and promotional expenditures serve as a primary engine for market growth, as manufacturers heavily invest in high-quality visual assets to distinguish their therapies in a crowded marketplace. To clarify complex Mechanisms of Action (MOA) for both physicians and Direct-to-Consumer (DTC) audiences, companies utilize medical animation to convert static clinical data into engaging, easily understood narratives. This trend is supported by financial data; according to Fierce Pharma in June 2025, pharmaceutical companies directed over $10.1 billion toward marketing prescription drugs across all channels in 2024, generating substantial demand for digital content production. This escalation in promotional efforts guarantees a consistent flow of contracts for animation studios equipped to provide scientifically accurate and compliant visual storytelling.

Additionally, the proliferation of digital health platforms and mobile applications accelerates demand, especially as software becomes central to modern medical devices and patient care strategies. As diagnostic and patient management tools increase in sophistication, clear animated instructions and interface visualizations become critical for ensuring user safety and adherence. According to MedTech Dive in May 2025, the U.S. Food and Drug Administration had authorized roughly 950 AI or machine learning-enabled medical devices by that date, creating a need for extensive libraries of instructional visuals to support their rollout. Broader industry investment underpins this expansion; according to the Association of the British Pharmaceutical Industry, in 2025, global pharmaceutical R&D investment maintained a compound annual growth rate of 6.6% in recent years, fueling a continuous pipeline of innovations that require visualization.

Market Challenge

The significant expense of production, exacerbated by a shortage of specialized talent, poses a major barrier to the expansion of the Global Medical Animation Market. This dual difficulty limits market penetration by rendering high-quality visualizations financially out of reach for a substantial portion of potential clients, specifically smaller healthcare providers, academic institutions, and regional medical device manufacturers. Although the demand for accurate scientific visualization is rising, the supply side's inability to scale production cost-effectively creates a bottleneck. As a result, the market remains dominated by wealthy pharmaceutical giants, leaving the broader mid-tier sector underserved and constraining overall revenue volume.

The fundamental cause of this financial inflexibility is a lack of qualified professionals. Creating medically accurate 3D content demands a workforce possessing a rare blend of advanced life sciences education and technical skill in animation software. This scarcity drives labor costs upward as studios vie for a limited number of experts. According to the Association of Medical Illustrators, the industry pipeline remained critically narrow in 2024, with only 50 to 60 accredited master's level graduates entering the field annually. This consistently low influx of specialized talent ensures that production costs remain elevated, thereby preventing the market from adopting more competitive pricing models that could stimulate broader growth.

Market Trends

The integration of generative AI for automated workflows is transforming the medical animation supply chain by significantly decreasing the time and capital needed for high-fidelity content creation. By automating labor-intensive tasks such as texturing, lighting, and preliminary modeling, studios can alleviate the industry's persistent talent shortage and high production costs, which have traditionally restricted market access. This move toward AI-driven efficiency is supported by immediate economic advantages; according to NVIDIA's 'State of AI in Healthcare and Life Sciences: 2025 Trends' report from March 2025, 45% of healthcare organizations utilizing generative AI reported a return on investment within less than 12 months. This operational acceleration enables agencies to provide competitive pricing, thereby opening the market to smaller healthcare providers and educational bodies that were previously excluded.

Concurrently, the rise of personalized and patient-specific visuals is shifting the sector from a producer of generic stock assets to a provider of bespoke therapeutic communication tools. With patient engagement becoming a priority, there is growing demand for animations that can be dynamically customized to individual pathologies rather than relying on standard anatomical representations, directly addressing health literacy challenges. This need is highlighted by the fight against inaccurate information; according to Elsevier Health's 'Clinician of the Future 2025' report from July 2025, 59% of clinicians noted that medical misinformation impedes patient compliance with recommended treatments. Consequently, the market is turning toward real-time rendering platforms that allow physicians to visualize specific surgical plans or disease progressions during consultations, ensuring accurate comprehension and adherence.

Key Market Players

• Wiley
• Elsevier
• XVIVO
• Nucleus Medical Media
• Blausen Medical
• Ghost Productions
• Anatomage
• Touch Surgery
• Medis Media
• BioDigital

Report Scope

In this report, the Global Medical Animation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Animation Market, By Type

• 3D Animation
• 2D Animation
• 4D Animation
• Flash Animation

Medical Animation Market, By Therapeutics Area

• Oncology
• Cardiology
• Plastic Surgery
• Dental
• Others

Medical Animation Market, By Application

• Drug MoA
• Patient Education
• Surgical Training & Planning
• Cellular & Molecular Studies
• Others

Medical Animation Market, By End User

• Hospitals
• Life Science Companies
• Academic Institutes
• Medical Device Manufacturers
• Others

Medical Animation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Animation Market.

Available Customizations:

Global Medical Animation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Animation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (3D Animation, 2D Animation, 4D Animation, Flash Animation)
  • 5.2.2. By Therapeutics Area (Oncology, Cardiology, Plastic Surgery, Dental, Others)
  • 5.2.3. By Application (Drug MoA, Patient Education, Surgical Training & Planning, Cellular & Molecular Studies, Others)
  • 5.2.4. By End User (Hospitals, Life Science Companies, Academic Institutes, Medical Device Manufacturers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Medical Animation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Therapeutics Area
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medical Animation Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Therapeutics Area
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Medical Animation Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Therapeutics Area
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Medical Animation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Therapeutics Area
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Medical Animation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Therapeutics Area
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Medical Animation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Therapeutics Area
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Medical Animation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Therapeutics Area
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Medical Animation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Therapeutics Area
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Medical Animation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Therapeutics Area
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Medical Animation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Therapeutics Area
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Medical Animation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Therapeutics Area
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Medical Animation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Therapeutics Area
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Medical Animation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Therapeutics Area
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Medical Animation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Therapeutics Area
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Medical Animation Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Therapeutics Area
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Medical Animation Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Therapeutics Area
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Medical Animation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Therapeutics Area
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Medical Animation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Therapeutics Area
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Medical Animation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Therapeutics Area
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Medical Animation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Therapeutics Area
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Medical Animation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Therapeutics Area
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Medical Animation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Therapeutics Area
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Medical Animation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Therapeutics Area
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Medical Animation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Therapeutics Area
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Medical Animation Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Wiley
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Elsevier
• 15.3. XVIVO
• 15.4. Nucleus Medical Media
• 15.5. Blausen Medical
• 15.6. Ghost Productions
• 15.7. Anatomage
• 15.8. Touch Surgery
• 15.9. Medis Media
• 15.10. BioDigital

16. Strategic Recommendations

17. About Us & Disclaimer